MultiCenter, Randomized, Double-Blind study of Rozanolixizumab in Subjects with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Administered By

Awarded By

Contributors

Start/End

  • August 17, 2020 - December 31, 2023